{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:58:50Z","timestamp":1761821930091,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.rec.2020.02.001","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T17:37:10Z","timestamp":1582565830000},"page":"345-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ambulatory levosimendan infusions. Effective and efficient in advanced heart failure?"],"prefix":"10.1016","volume":"73","author":[{"given":"David","family":"Dobarro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Ribera-Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2020.02.001_bib0140","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2020.02.001_bib0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11897-017-0351-y","article-title":"Acute heart failure: definition, classification and epidemiology","volume":"14","author":"Kurmani","year":"2017","journal-title":"Curr Heart Fail Rep."},{"key":"10.1016\/j.rec.2020.02.001_bib0150","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijcard.2013.12.028","article-title":"The annual global economic burden of heart failure","volume":"171","author":"Cook","year":"2014","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2020.02.001_bib0155","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.recesp.2018.05.037","article-title":"Population-based study of first hospitalizations for heart failure and the interaction between readmissions and survival","volume":"72","author":"Fern\u00e1ndez-Gass\u00f3","year":"2019","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2020.02.001_bib0160","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ejhf.549","article-title":"Medical resource use an expenditure in patients with chronic heart failure: a population-based analysis of 88,195 patients","volume":"18","author":"Farr\u00e9","year":"2016","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rec.2020.02.001_bib0165","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.recesp.2016.11.042","article-title":"Trends and characteristics of hospitalization for heart failure in a population setting from 2003 to 2013","volume":"70","author":"Fern\u00e1ndez Gass\u00f3","year":"2017","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2020.02.001_bib0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ehf2.12005","article-title":"Heart Failure: Preventing disease and death worldwide","volume":"1","author":"Ponikowski","year":"2014","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.rec.2020.02.001_bib0175","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2020.02.001_bib0180","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1911303","article-title":"for the DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction","author":"McMurray","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2020.02.001_bib0185","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2020.02.001_bib0190","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2020.02.001_bib0195","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1900486","article-title":"A fully magnetically levitated left ventricular assist device \u2014 final report","volume":"380","author":"Mehra","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2020.02.001_bib0200","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.healun.2013.04.004","article-title":"HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial","volume":"32","author":"Slaughter","year":"2013","journal-title":"J Heart Lung Transplant."},{"key":"10.1016\/j.rec.2020.02.001_bib0205","unstructured":"Ministerio de Sanidad, Consumo y Bienestar Social. Organizaci\u00f3n Nacional de Trasplantes. Memoria de actividad: Donaci\u00f3n y Trasplante Cardiaco. Espa\u00f1a 2018. Available at: http:\/\/www.ont.es\/infesp\/Memorias\/Actividad%20de%20Donaci\u00f3n%20y%20Trasplante%20Card\u00edaco.pdf. Accessed 21 Nov 2019."},{"key":"10.1016\/j.rec.2020.02.001_bib0210","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1067\/mhj.2003.50","article-title":"Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial","volume":"145","author":"Aranda","year":"2003","journal-title":"Am Heart J."},{"key":"10.1016\/j.rec.2020.02.001_bib0215","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/euhj.2001.3158","article-title":"RUSSLAN Study Investigators. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)","volume":"23","author":"Moiseyev","year":"2002","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2020.02.001_bib0220","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2020.02.001_bib0225","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/eurjhf\/hfn045","article-title":"Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE","volume":"11","author":"Mebazaa","year":"2009","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rec.2020.02.001_bib0230","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.rec.2020.02.001_bib0235","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCULATIONAHA.109.858076","article-title":"Selection of cardiac transplantation candidates in 2010","volume":"122","author":"Mancini","year":"2010","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2020.02.001_bib0240","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.recesp.2019.07.006","volume":"72","author":"Gonz\u00e1lez-V\u00edlchez","year":"2019","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2020.02.001_bib0245","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ejhf.118","article-title":"Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial","volume":"16","author":"Altenberger","year":"2014","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rec.2020.02.001_bib0250","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijcard.2017.05.081","article-title":"Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy","volume":"243","author":"P\u00f6lzl","year":"2017","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2020.02.001_bib0255","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ejhf.1145","article-title":"Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial","volume":"20","author":"Com\u00edn-Colet","year":"2018","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rec.2020.02.001_bib0260","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ehf2.12366","article-title":"Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period","volume":"6","author":"P\u00f6lzl","year":"2019","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.rec.2020.02.001_bib0265","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMp1011024","article-title":"What is value in health care?","volume":"363","author":"Porter","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2020.02.001_bib0270","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.recesp.2019.06.019","article-title":"en representaci\u00f3n de los investigadores del estudio LION-HEART. Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain","volume":"73","author":"Manito Lorite","year":"2020","journal-title":"Rev Esp Cardiol."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585720300396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585720300396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:57:01Z","timestamp":1761821821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585720300396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1885585720300396"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2020.02.001","relation":{},"ISSN":["1885-5857"],"issn-type":[{"type":"print","value":"1885-5857"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ambulatory levosimendan infusions. Effective and efficient in advanced heart failure?","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2020.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2019.06.020","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}